Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 21% ± 4% | |
glutamatergic neuron | 3 studies | 40% ± 10% |
Insufficient scRNA-seq data for expression of PIP4K2C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2461.15 | 578 / 578 | 100% | 80.04 | 1155 / 1155 |
ovary | 100% | 2123.09 | 180 / 180 | 100% | 67.81 | 430 / 430 |
esophagus | 100% | 2792.30 | 1444 / 1445 | 100% | 72.88 | 183 / 183 |
skin | 100% | 2714.07 | 1805 / 1809 | 100% | 82.67 | 472 / 472 |
stomach | 100% | 3265.22 | 359 / 359 | 100% | 55.27 | 285 / 286 |
uterus | 100% | 2593.38 | 170 / 170 | 99% | 63.56 | 456 / 459 |
breast | 100% | 2436.46 | 457 / 459 | 100% | 95.04 | 1115 / 1118 |
intestine | 100% | 2639.01 | 966 / 966 | 99% | 58.49 | 523 / 527 |
prostate | 100% | 2621.60 | 245 / 245 | 99% | 58.00 | 498 / 502 |
bladder | 100% | 2474.24 | 21 / 21 | 99% | 63.21 | 499 / 504 |
kidney | 100% | 3976.96 | 89 / 89 | 99% | 50.24 | 892 / 901 |
pancreas | 100% | 1611.55 | 327 / 328 | 99% | 66.48 | 176 / 178 |
thymus | 100% | 2552.40 | 653 / 653 | 99% | 53.86 | 596 / 605 |
adrenal gland | 100% | 2286.91 | 258 / 258 | 98% | 54.96 | 225 / 230 |
brain | 99% | 2712.93 | 2617 / 2642 | 97% | 59.18 | 687 / 705 |
liver | 99% | 1075.45 | 223 / 226 | 91% | 29.22 | 369 / 406 |
spleen | 100% | 2033.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 69.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 46.36 | 1 / 1 |
blood vessel | 100% | 4269.54 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1775.94 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 49.76 | 79 / 80 |
heart | 97% | 1263.15 | 831 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 1088.38 | 770 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1426.52 | 855 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 26.70 | 25 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902635 | Biological process | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process |
GO_2000786 | Biological process | positive regulation of autophagosome assembly |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0010506 | Biological process | regulation of autophagy |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0043229 | Cellular component | intracellular organelle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005886 | Cellular component | plasma membrane |
GO_0005776 | Cellular component | autophagosome |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0016308 | Molecular function | 1-phosphatidylinositol-4-phosphate 5-kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0016309 | Molecular function | 1-phosphatidylinositol-5-phosphate 4-kinase activity |
Gene name | PIP4K2C |
Protein name | Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma) |
Synonyms | PIP5K2C |
Description | FUNCTION: Phosphatidylinositol 5-phosphate 4-kinase with low enzymatic activity. May be a GTP sensor, has higher GTP-dependent kinase activity than ATP-dependent kinase activity. PIP4Ks negatively regulate insulin signaling through a catalytic-independent mechanism. They interact with PIP5Ks and suppress PIP5K-mediated PtdIns(4,5)P2 synthesis and insulin-dependent conversion to PtdIns(3,4,5)P3 . . |
Accessions | Q8TBX8 ENST00000550465.5 [Q8TBX8-3] ENST00000548264.1 F8VNT5 ENST00000540759.6 [Q8TBX8-1] H0YIJ6 ENST00000550095.5 ENST00000551772.5 F8VVB2 ENST00000550360.1 F8VU68 ENST00000354947.10 [Q8TBX8-1] ENST00000422156.7 [Q8TBX8-2] |